Counterpart Broker Reliability
Counterpart has no Broker Spot Score because the reviewed evidence is insufficient for a numerical assessment. Spot Scores assess documented reliability within the reviewed scope; they do not predict claims payment.
Assessment
Not Rated
No current Broker Spot Score is published. The evidence identifies provider-reported licensing for Counterpart Insurance Services, Inc., names capacity partners without a complete policy placement map, and does not establish an entity-specific conduct record. Missing information is not a negative finding, and an insurer rating or carrier relationship is not a Counterpart score.
Assessed entity: Counterpart Insurance Services, Inc.. Scope: Limited to the provider-published U.S. producer/surplus-lines-broker role of Counterpart Insurance Services, Inc.; does not decide any additional MGA authority or attribute insurer financial strength to Counterpart.
Assessed 2026-09-29 · Review due 2026-10-29
Evidence and Scope
Role: Broker. Scope: Limited to the provider-published U.S. producer/surplus-lines-broker role of Counterpart Insurance Services, Inc.; does not decide any additional MGA authority or attribute insurer financial strength to Counterpart.
Provider-published license disclosure
Counterpart identifies Counterpart Insurance Services, Inc. as its wholly owned U.S. subsidiary and reports NPN 19374834 and producer/surplus-lines-broker authority in 50 states and D.C. Product availability may vary. This is a provider-published disclosure.[1]
Capacity and policy obligations
Counterpart names Aspen Specialty Insurance Company, Evanston Insurance Company and Westfield Specialty as underwriters, but the public sources do not allocate each issuer to every product/state/policy. The about-page rating note is dated February 26, 2024 and applies to named insurers, not Counterpart.[2][1]
Announced future risk retention
Evidence gaps
- Delegated MGA/program authority is not resolved by the producer/broker disclosure.
- Current authority or policy issuance by Counterpart Insurance Company is not established.
- No complete product/state/policy issuer mapping is published in the reviewed material.
- No audited financial evidence for Counterpart or Counterpart Insurance Company reviewed; venture funding is not insurer financial strength.
- Claim adjustment/payment responsibility and independently measured claims outcomes remain unresolved.
- No provider-level enforcement result or misconduct conclusion proposed; inaccessible review searches are not conduct evidence.
- No eligible customer-average review metric found.
Jurisdiction searches
| Jurisdiction | Result | Notes |
|---|---|---|
| USU.S. States And District Of Columbia | Company-reported disclosure[1] | Counterpart’s own license page is the source for this company-reported disclosure. It reports producer and surplus-lines-broker scope in 50 states and D.C. and says product availability may vary; no regulator verification is represented. |
Licenses and Authority
These are reviewed authority records for the named legal entities and scope. A license record does not establish that a particular policy is available, bound, or suitable.
| Entity and jurisdiction | Identifier | License class and authority |
|---|---|---|
| Counterpart Insurance Services, Inc.USUnited States: 50 States And District Of Columbia, As Reported By Counterpart | National Producer Number: 19374834[1] | Insurance producer; surplus-lines broker; Provider-published disclosure reports this authority; product availability may vary by state. |
Sources
- Licenses & Carriers. Counterpart Insurance Services, Inc.; Provider-published reported NPN 19374834, entity, producer/surplus-lines role, 50 states + D.C.; carrier and obligation boundary. Not independent regulator verification. Accessed 2026-09-28.
- About Counterpart. Counterpart, Inc.; Names Aspen, Evanston/Markel, Westfield; not complete line/state placement map. Rating footnote is dated 2024-02-26. Accessed 2026-09-29.
- Counterpart press articles. Counterpart press site; May 2026 future first-time risk retention through Counterpart Insurance Company; no evidence current policy issuance. Accessed 2026-09-29.
